CerS2 ko in vivo reduces pro-inflammatory ceramides and improves doxorubicin mediated cardiotoxicityTom Kretzschmar, P. Christian Schulze, Markus H. Graeler et al.|European Heart Journal|2023Cited by 2
Doxorubicin induced cardiotoxicity is mediated by increased CerS2 expression and ceramide accumulation in vitro and in vivoTom Kretzschmar, P. Christian Schulze, Jasmine Wu et al.|European Heart Journal|2021Cited by 1